Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIERCE: IV Ferric Carboxymaltose vs Oral Ferrous Sulfate in Anemia from GIB
NCT05060731Phase 4Not yet recruiting
- Sponsor
- University of Pécs
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by University of Pécs. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05060731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060731.